Quanticate doubles its footprint in India

David Underwood, CEO and Praveen Das, VP of clinical data management and head of Indian operations.

New center of excellence to support further development of collaborative, long-term partnerships with leading pharmaceutical companies.

Strategically located in Bangalore, with access to the country’s extensive talent pool in the pharmaceutical services industry, the new office will be a base from which Quanticate will broaden its capabilities for the management, analysis and reporting of data from clinical trials and post-marketing surveillance.

The decision to open the office follows a very successful year for Quanticate, which saw an increase in sales driving the demand for more resources both in India and further afield. The new 16,500-sq. ft. premises doubles the company’s current footprint in the country.

Praveen Dass, VP of clinical data management and head of Indian operations at Quanticate explains: “By expanding our presence in India, we are able to increase our capacity meaning we can cater for more clients on a larger scale.

“We have an ambitious growth strategy to deliver over the next 5 years, which aims to employ over 60 new members of staff in the coming months. Our new office provides the perfect platform for this growth and marks an important milestone in our journey.”

As the company’s new operational center of excellence, the facility will also help Quanticate to provide outstanding customer service for its global client base and support further development of collaborative, long-term partnerships with leading pharmaceutical companies.

The CROs increased presence in the region has recently allowed Quanticate to engage with a diverse range of industry-specific groups, including the Society for Clinical Data Management (SCDM) India and Pharmaceutical Users Software Exchange (PhUSE) India. The company has representatives on the steering committee and co-chaired the first Society for Clinical Data Management (SCDM) Single Day Event (SDE).